JVMCX
Price
$28.02
Change
+$0.13 (+0.47%)
Updated
Oct 8 closing price
Net Assets
24.11B
PMVEX
Price
$26.91
Change
+$0.08 (+0.30%)
Updated
Oct 8 closing price
Net Assets
165.78M
Interact to see
Advertisement

JVMCX vs PMVEX

Header iconJVMCX vs PMVEX Comparison
Open Charts JVMCX vs PMVEXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.02
Change+$0.13 (+0.47%)
VolumeN/A
Net Assets24.11B
PGIM Quant Solutions Mid-Cap Val R2
Price$26.91
Change+$0.08 (+0.30%)
VolumeN/A
Net Assets165.78M
JVMCX vs PMVEX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. PMVEX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and PMVEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.1B vs. PMVEX (166M). PMVEX pays higher dividends than JVMCX: PMVEX (1.22) vs JVMCX (0.00). JVMCX was incepted earlier than PMVEX: JVMCX (14 years) vs PMVEX (8 years). PMVEX (25.08) is less costly to investors than JVMCX (1.86). PMVEX is a more actively managed with annual turnover of: 97.00 vs. JVMCX (49.00). PMVEX has a lower initial minimum investment than JVMCX: PMVEX (0) vs JVMCX (1000). PMVEX annual gain was more profitable for investors over the last year : 8.37 vs. JVMCX (-2.65). PMVEX return over 5 years is better than : 91.81 vs. JVMCX (42.10).
JVMCXPMVEXJVMCX / PMVEX
Total Expense Ratio1.851.23150%
Annual Report Gross Expense Ratio1.8625.087%
Fund Existence14 years8 years-
Gain YTD10.2379.109112%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.1B166M14,518%
Annual Yield % from dividends0.001.22-
Returns for 1 year-2.658.37-32%
Returns for 3 years25.8244.8758%
Returns for 5 years42.1091.8146%
Returns for 10 years40.81N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEMX17.03N/A
N/A
Parametric Emerging Markets C
LGPSX41.20N/A
N/A
ProFunds Large Cap Growth Svc
ITCTX26.37N/A
N/A
VY® T. Rowe Price Capital Apprec S2
BRXCX16.50N/A
N/A
MFS Blended Research Intl Eq C
WENRX67.79N/A
N/A
Allspring Mid Cap Growth Fund - Cl R6